171 results
Page 6 of 9
8-K
EX-10.1
xyyouw
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
6zx5zgyy0phoxac
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am
8-K
EX-99.1
pgb2lb4j
6 May 19
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
7:08am
8-K/A
EX-99.1
vzdin
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
i8z dzeyjt
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
wn1h7o
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
S-3ASR
EX-23.2
osq3f6io2a3
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
47353qq9hk7e
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
6wy0gtq 1fabs8vljy
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
xfj9i2b0ekpa62jio8
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
ssc 9krt9qys01hm9
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am